Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study"
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. | Radiation Oncology BioMed Central Open Access Study protocol Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer report from the Quality Assurance Working Party of the randomised phase III ROSeL study Coen W Hurkmans 1 Johan P Cuijpers2 Frank J Lagerwaard2 Joachim Widder3 Uulke A van der Heide4 Danny Schuring1 and Suresh Senan2 Address Department of Radiation Therapy Catharina Hospital Eindhoven The Netherlands 2Department of Radiation Oncology VU University Medical Center Amsterdam The Netherlands 3Department of Radiation Oncology University Medical Center Groningen Groningen The Netherlands and 4Department of Radiation Oncology University Medical Center Utrecht Utrecht The Netherlands Email Coen W Hurkmans - coen.hurkmans@catharina-ziekenhuis.nl Johan P Cuijpers - jp.cuijpers@vumc.nl Frank J Lagerwaard - fj.lagerwaard@vumc.nl Joachim Widder - j.widder@rt.umcg.nl Uulke A van der Heide - u.a.vanderheide@umcutrecht.nl Danny Schuring - danny.schuring@catharina-ziekenhuis.nl Suresh Senan - s.senan@vumc.nl Corresponding author Published 12 January 2009 Received 24 September 2008 Radiation Oncology 2009 4 1 doi 10.1186 1748-7I7X-4-1 Accepted 12 Januaty 2009 This article is available from http www.ro-journal.eom content 4 1 1 2009 Hurkmans et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract__ Background A phase III multi-centre randomised trial ROSEL has been initiated to establish the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to rapid changes in radiotherapy technology and evolving techniques for image-guided delivery guidelines had to be developed